share_log

D: Filing D

D: Filing D

D:發行公告
美股SEC公告 ·  07/26 16:10
Moomoo AI 已提取核心訊息
SeaStar Medical Holding Corp has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an offering of securities. The filing, dated July 26, 2024, reports that the company, incorporated in Colorado in 2020, has successfully sold $10 million worth of securities, including common stock and equivalents, as well as warrants. The offering was made under Rule 506(b) and did not involve a business combination transaction. SeaStar Medical did not disclose the issuer size and declined to provide the revenue or aggregate net asset value. The company has paid approximately $850,000 in placement agent fees and expenses related to the offering. The proceeds from the offering will not be used for payments to any executive officers, directors, or promoters. The company's executive team, including CEO Eric Schlorff and CFO David Green, along with other directors, are named in the filing. The securities offered are classified under the 'Other Health Care' industry group.
SeaStar Medical Holding Corp has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an offering of securities. The filing, dated July 26, 2024, reports that the company, incorporated in Colorado in 2020, has successfully sold $10 million worth of securities, including common stock and equivalents, as well as warrants. The offering was made under Rule 506(b) and did not involve a business combination transaction. SeaStar Medical did not disclose the issuer size and declined to provide the revenue or aggregate net asset value. The company has paid approximately $850,000 in placement agent fees and expenses related to the offering. The proceeds from the offering will not be used for payments to any executive officers, directors, or promoters. The company's executive team, including CEO Eric Schlorff and CFO David Green, along with other directors, are named in the filing. The securities offered are classified under the 'Other Health Care' industry group.
SeaStar Medical Holding Corp已向SEC提交了一份豁免證券發行通知書,表明發行證券的新通知。這份備案日期爲2024年7月26日的文件報告說,這家在2020年在科羅拉多州註冊的公司已經成功銷售了價值1000萬美元的證券,包括普通股和同類股,以及權證。此次發行是根據規則506(b)進行的,沒有涉及業務合併交易。SeaStar Medical沒有披露發行者規模,並拒絕提供營業收入或總資產淨值。該公司已支付了大約85萬美元的配售代理費和相關費用。此次發行的收益將不用於向任何高管、董事或推薦人支付款項。公司的執行團隊,包括CEO Eric Schlorff和CFO David Green以及其他董事,在備案文件中被列出。所發行的證券屬於“其他醫療保健”行業板塊。
SeaStar Medical Holding Corp已向SEC提交了一份豁免證券發行通知書,表明發行證券的新通知。這份備案日期爲2024年7月26日的文件報告說,這家在2020年在科羅拉多州註冊的公司已經成功銷售了價值1000萬美元的證券,包括普通股和同類股,以及權證。此次發行是根據規則506(b)進行的,沒有涉及業務合併交易。SeaStar Medical沒有披露發行者規模,並拒絕提供營業收入或總資產淨值。該公司已支付了大約85萬美元的配售代理費和相關費用。此次發行的收益將不用於向任何高管、董事或推薦人支付款項。公司的執行團隊,包括CEO Eric Schlorff和CFO David Green以及其他董事,在備案文件中被列出。所發行的證券屬於“其他醫療保健”行業板塊。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息